Young John, Green John, Farrin Amanda, Collinson Michelle, Hartley Suzanne, Smith Jane, Teale Elizabeth, Siddiqi Najma, Inouye Sharon K
Academic Unit for Ageing and Stroke Research, University of Leeds, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.
Academic Unit for Ageing and Stroke Research, Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.
Age Ageing. 2020 Jul 1;49(4):640-647. doi: 10.1093/ageing/afaa044.
to provide a preliminary estimate of the effectiveness of the prevention of delirium (POD) system of care in reducing incident delirium in acute hospital wards and gather data for a future definitive randomised controlled trial.
cluster randomised and controlled feasibility trial.
sixteen acute care of older people and orthopaedic trauma wards in eight hospitals in England and Wales.
patients 65 years and over admitted to participating wards during the trial period.
participating wards were randomly assigned to either the POD programme or usual care, determined by existing local policies and practices. The POD programme is a manualised multicomponent delirium prevention intervention that targets 10 risk factors for delirium. The intervention wards underwent a 6-month implementation period before trial recruitment commenced. Main outcome measure incidence of new-onset delirium measured using the Confusion Assessment Method (CAM) measured daily for up to 10 days post consent.
out of 4449, 3274 patients admitted to the wards were eligible. In total, 714 patients consented (713 registered) to the trial, thirty-three participants (4.6%) withdrew. Adherence to the intervention was classified as at least medium for seven wards. Rates of new-onset delirium were lower than expected and did not differ between groups (24 (7.0%) of participants in the intervention group versus 33 (8.9%) in the control group; odds ratio (95% confidence interval) 0.68 (0.37-1.26); P = 0.2225).
based on these findings, a definitive trial is achievable and would need to recruit 5220 patients in 26 two-ward hospital clusters. Trial registration: ISRCTN01187372. Registered 13 March 2014.
对预防谵妄(POD)护理系统在降低急性医院病房中谵妄发生率方面的有效性进行初步评估,并为未来的确定性随机对照试验收集数据。
整群随机对照可行性试验。
英格兰和威尔士8家医院的16个老年急性护理和骨科创伤病房。
试验期间入住参与病房的65岁及以上患者。
参与病房被随机分配到POD方案或常规护理,这由现有的当地政策和实践决定。POD方案是一种针对10个谵妄风险因素的多成分谵妄预防干预措施,采用手册化形式。干预病房在试验招募开始前有6个月的实施期。主要结局指标为使用意识模糊评估法(CAM)测量的新发谵妄发生率,在获得同意后最多10天内每天测量。
在4449名患者中,3274名入住病房的患者符合条件。共有714名患者同意(713名登记)参加试验,33名参与者(4.6%)退出。7个病房对干预措施的依从性被归类为至少中等。新发谵妄发生率低于预期,且两组之间无差异(干预组24名(7.0%)参与者,对照组33名(8.9%);优势比(95%置信区间)0.68(0.37 - 1.26);P = 0.2225)。
基于这些发现,可以进行一项确定性试验,需要在26个包含两个病房的医院集群中招募5220名患者。试验注册号:ISRCTN01187372。于2014年3月13日注册。